Dual-Action Silica Nanoparticles Spark Complete Remissions in Aggressive Prostate Cancer Models, Paving the Way for Human Clinical Trials
Executive Overview In a significant breakthrough for oncological research, a multi-disciplinary team of scientists from Weill Cornell Medicine and the...